SynBiotic SE

Recommendation

Buy

Price Target

€9.00

Upside

51.52%

Chart
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 3Y

€5.94

(€0.18) (-2.94%)
Realtime-Data from 16.09.2024 15:44:15
SynBiotic is a German Buy-and-Build cannabis platform company focusing on pharmaceuticals and dietary supplements, as well as on the research and development of new solutions based on cannabinoids and terpenes. The company covers the entire value chain. SynBiotic is continuously expanding its presence in all market sectors. Although the company's origins are in the wellness and food markets, SynBiotic has set itself the goal of fully exploiting the potential of the medical markets.
Ticker
SBX GY
Market Cap
€31.07 M
Enterprise Value
€33.85 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
104
Incorporated
2015
CEO
Daniel Kruse
Management & Founders
63.00%
Other institutional investors
26.00%
Free Float
11.00%
31.05.2024
Publication of annual report
30.06.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report

KPIs in EUR

KPI20222023e2024e
Sales8.17 M11.27 M13.51 M
EBITDA(7.41 M)(2.98 M)(1.83 M)
EBIT(25.92 M)(3.95 M)(2.91 M)
EPS(5.47)(0.48)(0.44)
FCF(7.44 M)(4.41 M)(2.00 M)

Valuation

KPI20222023e2024e
EV / Sales4.15x3.01x2.66x
EV / EBITDA(4.57x)(11.39x)(19.64x)
EV / EBIT(1.31x)(8.57x)(12.35x)
Price / Earnings(1.08x)(12.25x)(13.61x)
EV / FCF(4.55x)(7.68x)(17.97x)

Downloads

Latest Research

Analyst

Christian Sandherr

Equity Research

Latest Research

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.